Fidelity Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $712K | Buy |
|
|||||
|
2024
Q3 | $1.11M | Buy |
|
|||||
|
2024
Q2 | $429K | Buy |
|
|||||
|
2024
Q1 | $37.5K | Buy |
|
|||||
|
2023
Q4 | $16.1K | Sell |
|
|||||
|
2023
Q3 | $21.7M | Sell |
|
|||||
|
2023
Q2 | $49.5M | Buy |
|
|||||
|
2023
Q1 | $59.4M | Buy |
|
|||||
|
2022
Q4 | $33.4M | Buy |
|
|||||
|
2022
Q3 | $47.2M | Buy |
|
|||||
|
2022
Q2 | $16.8M | Sell |
|
|||||
|
2022
Q1 | $24M | Buy |
|
|||||
|
2021
Q4 | $19.3M | Sell |
|
|||||
|
2021
Q3 | $75M | Sell |
|
|||||
|
2021
Q2 | $79.9M | Sell |
|
|||||
|
2021
Q1 | $77.6M | Sell |
|
|||||
|
2020
Q4 | $80.8M | Buy |
|
|||||
|
2020
Q3 | $48K | Sell |
|
|||||
|
2020
Q2 | $186K | Hold |
|
|||||
|
2020
Q1 | $112K | Sell |
|
|||||
|
2019
Q4 | $123K | Buy |
|
|||||
|
2019
Q3 | $0 | Sell |
|
|||||
|
2019
Q2 | $459K | Sell |
|
|||||
|
2019
Q1 | $1.01M | Sell |
|
|||||
|
2018
Q4 | $1.75M | Sell |
|
|||||
|
2018
Q3 | $8.7M | Buy |
|
|||||
|
2018
Q2 | $2.97M | Sell |
|
|||||
|
2018
Q1 | $7.57M | Buy |
|
|||||
|
2017
Q4 | $7.21M | Sell |
|
|||||
|
2017
Q3 | $6.87M | Sell |
|
|||||
|
2017
Q2 | $8.6M | Buy |
|
|||||
|
2017
Q1 | $6.59M | Buy |
|
|||||
|
2016
Q4 | $2.07M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $19M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $19.9M | Buy |
|
|||||
|
2014
Q2 | $34.1M | Buy |
|
|||||
|
2014
Q1 | $9.55M | Buy |
|